Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Moderna's stock has been under scrutiny following its recent announcement of a revised financial plan and updates to its mRNA-based pipeline. CEO On Thursday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Moderna Inc (NASDAQ:MRNA). This decision comes amidst a backdrop of mixed analyst sentiments and Moderna's recently unveiled post-COVID roadmap.
週四，凱西·伍德領導的方舟投資採取了重大舉措，出售了Moderna Inc（納斯達克股票代碼：MRNA）的股票。這一決定是在分析師情緒喜憂參半以及Moderna最近公佈的後COVID路線圖的背景下做出的。
The Moderna Trade
摩德納貿易
Ark Invest's ARK Genomic Revolution ETF (BATS:ARKG) and ARK Innovation ETF (NYSE:ARKK) sold a total of 160,994 shares of Moderna. The value of the trade, based on Moderna's closing price of $56.83 on the day of the trade, is approximately $9.15 million.
方舟投資旗下的方舟基因組革命ETF（BATS: ARKG）和方舟創新ETF（紐約證券交易所代碼：ARKK）共出售了Moderna的160,994股股票。根據Moderna在交易當天的收盤價56.83美元，該交易的價值約爲915萬美元。
Moderna's stock has been under scrutiny following its recent announcement of a revised financial plan and updates to its mRNA-based pipeline. CEO Stéphane Bancel highlighted the company's success in respiratory vaccines and outlined a focus on five non-respiratory products aiming for approvals by 2027.
Moderna最近宣佈了修訂後的財務計劃並更新了基於mRNA的產品線，其股票一直受到審查。首席執行官斯蒂芬·班塞爾強調了該公司在呼吸道疫苗方面的成功，並概述了重點關注五種非呼吸道產品，目標是到2027年獲得批准。
However, the biotech company's future prospects have elicited mixed reactions from analysts. Over the past three months, 16 analysts have shared their evaluations, with the average 12-month price target standing at $111.50, a decrease of 18.06% from the previous average.
但是，這家生物技術公司的未來前景引起了分析師的不同反應。在過去的三個月中，有16位分析師分享了他們的評估，12個月的平均目標股價爲111.50美元，較之前的平均水平下降了18.06％。
Other Key Trades:
其他關鍵交易：
ARK Autonomous Technology & Robotics ETF (ARKQ) bought 3,589 shares of Advanced Micro Devices Inc (AMD) worth $589,242.
Ark Autonomous Technology & Robotics ETF（ARKQ）購買了價值589,242美元的先進微設備公司（AMD）3589股股票。
Ark Invest's ARKG and ARKK bought a total of shares of 10X Genomics Inc (TXG).
方舟投資旗下的ARKG和ArkK共購買了10X Genomics Inc（TXG）的股份。
ARKK also purchased shares of CRISPR Therapeutics AG (CRSP).
ArkK還購買了CRISPR Therapeutics AG（CRSP）的股份。
Blade Air Mobility Inc (BLDE), and 3D Systems Corp (DDD) while selling shares of Materialise NV (MTLS) and Markforged Holding Corp (MKFG).
Blade Air Mobility Inc（BLDE）和3D Systems Corp（DDD）同時出售Materialise NV（MTLS）和Markforged Holding Corp（MKFG）的股份。
Image via Flickr/ WEF
圖片來自 Flickr/ WEF
- Trump Considers Pro-Crypto Vivek Ramaswamy For Key Administration Role: 'He'll Do A Better Job Than Anybody'
- 特朗普考慮讓支持加密貨幣的維維克·拉馬斯瓦米擔任關鍵的政府職務：「他會比任何人做得更好」
This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal
這個故事是使用 Benzinga Neuro 創作的，由 Shivdeep Dhaliwal
譯文內容由第三人軟體翻譯。
